"Wiskott-Aldrich Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.
| Descriptor ID |
D014923
|
| MeSH Number(s) |
C15.378.100.100.970 C15.378.463.960 C15.378.553.546.605.900 C16.320.099.970 C16.320.322.937 C20.673.627.900
|
| Concept/Terms |
Wiskott-Aldrich Syndrome- Wiskott-Aldrich Syndrome
- Syndrome, Wiskott-Aldrich
- Wiskott Aldrich Syndrome
- Wiskott Syndrome
- Imd2
- Immunodeficiency 2
- Aldrich Syndrome
- Syndrome, Aldrich
- Eczema-Thrombocytopenia-Immunodeficiency Syndrome
- Eczema Thrombocytopenia Immunodeficiency Syndrome
- Eczema-Thrombocytopenia-Immunodeficiency Syndromes
- Syndrome, Eczema-Thrombocytopenia-Immunodeficiency
- Syndromes, Eczema-Thrombocytopenia-Immunodeficiency
|
Below are MeSH descriptors whose meaning is more general than "Wiskott-Aldrich Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Wiskott-Aldrich Syndrome".
This graph shows the total number of publications written about "Wiskott-Aldrich Syndrome" by people in this website by year, and whether "Wiskott-Aldrich Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Wiskott-Aldrich Syndrome" by people in Profiles.
-
Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon. Clin Immunol. 2020 10; 219:108573.
-
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12; 6(227):227ra33.